VGFT-OD-1009

Status: Completed

TG-MV-014: Study of Ocriplasmin in patients with symptomatic vitreomacular adhesion/(VMT) including macular hole.

ClinicalTrials.gov Identifier: NCT01429441

Condition:

  • Vitreomacular Adhesion including Macular Hole

Study Type: Interventional

Duration: 3 years

Eligibility:

  • Ages: 18 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

 

For more information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.